Biomarker: KL-6 (Krebs von den Lungen-6)

An add-on marker for the diagnostic and management of Interstital Lung Diseases (ILDs)

Krebs von den Lungen 6 (KL-6) is a mucin-like, highmolecular weight glycoprotein expressed on the surface membrane of alveolar epithelial cells (AEC-II) and bronchiolar epithelial cells. It exists as solubilized component in the pulmonary epithelial lining fluid by proteolytic cleavage.


  • When these cells are proliferating, stimulated or injured, KL-6 is released into the blood vessel (damaged barrier).
  • KL-6 has chemotactic, proliferative effects on fibroblasts. It correlates with fibrogenesis.
  • KL-6 is a good marker of AEC injury. Its role in patients with Interstital Lung Diseases (ILDs) and connective tissue diseases has been extensively studied1.


  1. Ishikawa et al. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. RESPIRATORY INVESTIGATION 2012; 50:3–13

Lumipulse® G KL-6 (Krebs von den Lungen)

KL-6 is an add-on marker for the diagnostic and management of Interstital Lung Diseases (ILDs). Our Lumipulse G immunoreaction cartridges are for in vitro diagnostic (IVD) use with the fully automated LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.

Read more here

You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below:

Welcome to Fujirebio

It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors.

If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals.

Please contact your country representative for further details.